Defining Musical Toxicity and Its Effect on Patient Well-being

NCT ID: NCT06494046

Last Updated: 2025-06-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2024-08-15

Study Completion Date

2025-05-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates the experience of musicians who are going through cancer treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PRIMARY OBJECTIVES:

I. Describe specific musical difficulties that arise during and after cancer treatments: define "musical toxicity".

II. Discover any interventions or treatments which musicians found helpful while going through cancer treatment.

III. Investigate whether the priority of playing music changed through the course of cancer treatment and beyond, in relation to other priorities including cancer cure and length of life.

IV. Discover treatment and cancer related factors which are correlated with worse musical toxicity.

OUTLINE: This is an observational study. Patients are assigned to 1 of 2 groups.

MUSICAL TOXICITY GROUP: Patients complete a questionnaire, participate in an interview and have their medical records reviewed on study.

NO MUSICAL TOXICITY GROUP: Patients have their medical records reviewed on study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Carcinoma Esophageal Carcinoma Head and Neck Carcinoma Lung Carcinoma Malignant Brain Neoplasm Malignant Solid Neoplasm

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Observational Musical Toxicity Group

Patients complete a questionnaire, participate in an interview and their medical records reviewed on study.

Non-Interventional Study

Intervention Type OTHER

Non-Interventional Study

Observational No Musical Toxicity Group

Patients have their medical records reviewed on study.

Non-Interventional Study

Intervention Type OTHER

Non-Interventional Study

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Non-Interventional Study

Non-Interventional Study

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* \* Adults ≥ 18 years or older

* Active or accomplished musicians

* Those performing in the community as part of a group or as a soloist
* Those teaching lessons in an individual or group setting
* Those for whom music teaching or performance is a primary source of income
* Those who play music multiple times per week
* Our ideal cohort will consist of an equal number of patients with the following malignancies above the diaphragm:

* Brain
* Head and Neck
* Esophagus or Lung
* Breast
* Our ideal cohort will consist of an equal number of patients who engage in the following musical endeavors:

* Stringed instruments
* Wind instruments (including woodwind and brass instruments)
* Keyboard instruments
* Vocalists

Exclusion Criteria

* \* \< 18 years

* Did not regularly attempt to engage in musical endeavors during or after cancer treatment
* Not willing or able to complete the questionnaire or engage in a one-hour interview (i.e. limited English proficiency)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mayo Clinic

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dean A. Shumway, M.D.

Role: PRINCIPAL_INVESTIGATOR

Mayo Clinic in Rochester

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mayo Clinic in Rochester

Rochester, Minnesota, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NCI-2024-05423

Identifier Type: REGISTRY

Identifier Source: secondary_id

23-012760

Identifier Type: OTHER

Identifier Source: secondary_id

ROR2333

Identifier Type: OTHER

Identifier Source: secondary_id

ROR2333

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.